2 ms·
“The drug, lepodisiran, reduced levels of lipoprotein(a), or Lp(a), by an average of 93.9% versus placebo over six months after one or two 400 milligram doses”
by melling 2y ago
“The drug, lepodisiran, reduced levels of lipoprotein(a), or Lp(a), by an average of 93.9% versus placebo over six months after one or two 400 milligram doses”